Nitin Lifesciences Limited was founded in 1994 and is based in Karnal, Haryana, with a manufacturing facility. Nitin became a powerful force with significant effects on the production of injectables over time. One of India's biggest small-volume parenteral producers, Nitin provides contract manufacturing services to MNCs and all of the country's leading pharmaceutical companies.
A significant international contract development and manufacturing company, Recipharm, Sweden, purchased the bulk of Nitin's shares in 2016. Through the network and assistance of Recipharm, Nitin was able to grow both inside and outside of the Indian market. One of India's biggest CDMOs, Synokem Pharmaceuticals Ltd., purchased M/s. Nitin Lifesciences Ltd. in 2023, bringing Nitin under Synokem's ownership.
Nitin, which has its headquarters in National Capital Delhi, operates three state-of-the-art facilities for small-volume parenterals, the most recent of which opened for business in 2014. The facilities are situated in Paonta Sahib (Himachal Pradesh), 248 kilometers from Delhi, and Karnal (Haryana), around 120 kilometers from the nation's capital.
A significant international contract development and manufacturing company, Recipharm, Sweden, purchased the bulk of Nitin's shares in 2016. Through the network and assistance of Recipharm, Nitin was able to grow both inside and outside of the Indian market. One of India's biggest CDMOs, Synokem Pharmaceuticals Ltd., purchased M/s. Nitin Lifesciences Ltd. in 2023, bringing Nitin under Synokem's ownership.
Nitin, which has its headquarters in National Capital Delhi, operates three state-of-the-art facilities for small-volume parenterals, the most recent of which opened for business in 2014. The facilities are situated in Paonta Sahib (Himachal Pradesh), 248 kilometers from Delhi, and Karnal (Haryana), around 120 kilometers from the nation's capital.